Orabloc (Articaine Hydrochloride, Epinephrine)

Articaine hydrochloride, the active ingredient in Orabloc, is a local anesthetic (amide) presented as a dental formulation for intra‑oral use. It produces reversible blockade of nerve conduction, allowing clinicians to perform tooth extractions, restorations, and other dental procedures with reduced pain in adult patients.

GNH USA supplies Orabloc as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and provides reliable logistics for global distribution, ensuring timely delivery and regulatory compliance.

Orabloc (articaine) is used as a local anesthetic in dental practice to achieve reversible nerve block.

- Tooth extraction: provides analgesia for removal of teeth. - Restorative dentistry: facilitates painless cavity preparation and filling. - Periodontal surgery: enables comfortable soft‑tissue procedures.

Adverse reactions may occur following administration of Orabloc.

Common Side Effects: - Transient numbness of the injected area. - Mild swelling or bruising at the injection site. - Temporary alteration of taste. - Lightheadedness or dizziness. - Mild headache. - Localized itching or rash.

Serious or Rare Side Effects: - Allergic reaction, including anaphylaxis. - Cardiovascular toxicity from epinephrine (e.g., hypertension, arrhythmia). - Methemoglobinemia (rare). - Seizure activity (very rare).

Before using Orabloc, consider the following safety measures.

- Allergy assessment: avoid in patients with known hypersensitivity to articaine, other amide anesthetics, or epinephrine. - Cardiovascular status: use caution in patients with uncontrolled hypertension or significant cardiac disease due to epinephrine effects. - Pregnancy: safety category unknown; prescribe only if benefits outweigh potential risks. - Pediatric use: limit to recommended concentrations and volumes; adjust technique for children. - Drug interactions: monitor closely when combined with non‑selective MAO inhibitors or other sympathomimetics. - Store at room temperature: keep in the original container, protect from light and moisture.

Orabloc may interact with other medicines; awareness of the interaction level is essential.

Major Interactions (Avoid): - Non‑selective MAO inhibitors: risk of hypertensive crisis with epinephrine. - Beta‑blockers: may potentiate epinephrine‑induced cardiovascular effects.

Moderate Interactions (Monitor Closely): - Tricyclic antidepressants: may increase cardiovascular stimulation. - Antihypertensive agents: may require adjustment of epinephrine dose. - Other local anesthetics: cumulative toxicity risk if combined.